Inflachromene (ICM) is primarily used in research settings to study its anti-inflammatory and neuroprotective properties. It has shown potential in inhibiting microglial activation, which is crucial in neuroinflammatory conditions. This makes ICM a valuable compound for investigating therapeutic strategies for neurodegenerative diseases such as Alzheimer's and Parkinson's. Additionally, its ability to modulate inflammatory pathways has sparked interest in exploring its use in treating chronic inflammatory disorders. Researchers are also examining its potential in reducing oxidative stress and its role in protecting neuronal cells, which could lead to advancements in neuroprotection and brain health.